Drug intelligence / Profile preview

PKU GOLIKE

Development stage
Unknown
Lead developer
APR Applied Pharma Research
Modality
Small Molecules
Administration
Oral
01

Overview

PKU GOLIKE® is a phenylalanine-free amino acid mixture developed by APR Applied Pharma Research (a subsidiary of Relief Therapeutics) for the dietary management of phenylketonuria (PKU). The product is engineered using the proprietary Physiomimic™ Technology, which creates a modified-release profile for the amino acids, allowing them to be absorbed in a manner that mimics natural dietary protein. This technology also serves to mask the characteristic unpleasant taste and odor of free amino acids, improving patient adherence. PKU GOLIKE is designed to support metabolic balance by reducing phenylalanine fluctuations and preventing muscle proteolysis. It is classified as a Food for Special Medical Purposes (FSMP) in the European Union and is marketed as a prescription medical food in the United States, where it also holds Orphan Drug Designation.

Brand names
PKU GOLIKE
Other names
physiomimic phenylalanine-free amino acid mixtureAPR-OD031APR-OD-031APR-OD 031

Beyond the preview

Go deeper on PKU GOLIKE.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PKU GOLIKE.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call